• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly November 2008

CenterWatch Monthly November 2008

November 4, 2008
CenterWatch Staff

No Standard Policy for Conflicts of Interest

Many research organizations have taken actions to strengthen their policies for managing financial conflicts in recent years. Despite individual organizations’ efforts, there are no universally accepted standards for managing conflicts of interest in clinical research. Nor is there a model policy to aid institutions in the development of their own policies.

Medical Writing Takes Off in India

Medical writing is the latest niche CRO service to be a focus in India. India-based company Cactus Communications has opened an office in the U.S., positioning itself to become a player in Western markets. With an English-speaking, highly skilled workforce and an infrastructure that meets international standards, India can expect to see more niche CRO services outsourced there.

Pediatric Networks Coming Into Their Own

Two years after the European pediatric regulation went into effect, its mandate to create a European pediatric network of research. The need for dedicated pediatric networks is clear. About 20% of the EU population, or about 100 million, are less than 16 years old. Between 50% and 90% of pediatric medicines have not been tested and evaluated. Between 15% and 20% of rare diseases only affect children, and 55% affect both adults and children. A budget of 30 million euros has been dedicated to pediatric research funding for studies into off-patent medicinal products for the first two years of the program.

Eye On: Cardiovascular Diseases

Heart disease is now the number one cause of death among adult women as well as adult men in both the United States and Europe. Acute myocardial infarction (AMI), or heart attack, results from atherosclerotic blockage of the main arteries supplying the heart muscle. AMI is the leading cause of cardiovascular death in the developed world, with more than 2 million new cases each year in the United States, Western Europe and Japan.

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing